Analyst Activity – Bank of America Corporation Reiterates Buy on Ascendis Pharma A/S (NASDAQ:ASND)

Analyst Ratings For Ascendis Pharma A/S (NASDAQ:ASND)

Story continues below

Today, Bank of America Corporation reiterated its Buy rating on Ascendis Pharma A/S (NASDAQ:ASND) with a price target of $36.00.

There are 1 hold rating, 5 buy ratings on the stock.

The current consensus rating on Ascendis Pharma A/S (NASDAQ:ASND) is Buy (Score: 2.83) with a consensus target price of $35.29 per share, a potential 3.05% upside.

Some recent analyst ratings include

  • 9/25/2017-Bank of America Corporation Reiterated Rating of Buy.
  • 9/22/2017-Wells Fargo & Company Reiterated Rating of Buy.
  • 9/22/2017-Credit Suisse Group Reiterated Rating of Outperform.
  • 9/22/2017-Wedbush Reiterated Rating of Outperform.
  • 9/1/2017-Leerink Swann Reiterated Rating of Hold.
  • 5/11/2017-J P Morgan Chase & Co initiated coverage with a Overweight rating.

    Recent Trading Activity for Ascendis Pharma A/S (NASDAQ:ASND)
    Shares of Ascendis Pharma A/S closed the previous trading session at with shares trading hands.

    An ad to help with our costs